NURCHI, VALERIA MARINA
 Distribuzione geografica
Continente #
EU - Europa 246.479
NA - Nord America 15.496
AS - Asia 6.428
SA - Sud America 1.024
AF - Africa 176
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 6
Totale 269.636
Nazione #
IT - Italia 239.560
US - Stati Uniti d'America 15.266
NL - Olanda 2.972
SG - Singapore 2.458
CN - Cina 2.266
UA - Ucraina 1.148
BR - Brasile 809
SE - Svezia 799
VN - Vietnam 527
DE - Germania 515
FI - Finlandia 443
GB - Regno Unito 364
FR - Francia 323
HK - Hong Kong 191
IN - India 189
KR - Corea 169
CA - Canada 140
BD - Bangladesh 80
IQ - Iraq 73
TR - Turchia 73
RU - Federazione Russa 71
AR - Argentina 63
MX - Messico 61
IR - Iran 54
JP - Giappone 53
ZA - Sudafrica 52
PL - Polonia 48
ES - Italia 44
EC - Ecuador 40
PK - Pakistan 39
UZ - Uzbekistan 35
ID - Indonesia 32
MY - Malesia 29
AT - Austria 28
BE - Belgio 28
CO - Colombia 28
AU - Australia 25
PH - Filippine 23
MA - Marocco 22
EG - Egitto 21
IE - Irlanda 21
VE - Venezuela 21
TN - Tunisia 20
CH - Svizzera 18
CL - Cile 18
UY - Uruguay 18
SA - Arabia Saudita 17
KE - Kenya 14
TH - Thailandia 13
IL - Israele 12
DZ - Algeria 11
LY - Libia 11
PE - Perù 11
SY - Repubblica araba siriana 11
CZ - Repubblica Ceca 10
JO - Giordania 10
RO - Romania 9
AL - Albania 8
AZ - Azerbaigian 8
BG - Bulgaria 8
GR - Grecia 8
PY - Paraguay 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DK - Danimarca 7
LB - Libano 7
JM - Giamaica 6
KZ - Kazakistan 6
LT - Lituania 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
BY - Bielorussia 5
CR - Costa Rica 5
ET - Etiopia 5
HU - Ungheria 5
NG - Nigeria 5
PS - Palestinian Territory 5
PT - Portogallo 5
AM - Armenia 4
CI - Costa d'Avorio 4
EU - Europa 4
LK - Sri Lanka 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
KG - Kirghizistan 3
MD - Moldavia 3
MN - Mongolia 3
PA - Panama 3
BS - Bahamas 2
BW - Botswana 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
ME - Montenegro 2
Totale 269.611
Città #
Cagliari 234.871
Uta 3.910
Amsterdam 2.942
Fairfield 1.696
Ashburn 1.298
Woodbridge 1.283
Singapore 1.108
Houston 874
Chandler 832
San Jose 819
Dallas 724
Wilmington 695
Ann Arbor 688
Boardman 656
Seattle 626
Jacksonville 618
Cambridge 588
Nyköping 573
Beijing 400
Dearborn 338
Helsinki 260
Los Angeles 241
Nanjing 195
Lauterbourg 190
The Dalles 190
Boston 189
Santa Clara 181
Ho Chi Minh City 163
Hong Kong 163
Hefei 161
Seoul 153
New York 127
Hanoi 126
Shanghai 121
Buffalo 120
Council Bluffs 97
San Diego 93
Escalaplano 79
Guangzhou 73
Nanchang 72
São Paulo 71
Redwood City 70
Shenyang 61
Dong Ket 60
Hebei 57
London 51
Milan 51
Mountain View 51
Tianjin 51
Changsha 49
Orem 49
Toronto 49
Redondo Beach 46
Chennai 41
Jiaxing 39
Atlanta 38
Chicago 38
Verona 37
Baghdad 35
Frankfurt am Main 34
Tokyo 33
Norwalk 32
Ottawa 32
Sassari 32
Tashkent 32
Zhengzhou 32
Rio de Janeiro 30
Da Nang 27
Jinan 26
Orange 26
Brussels 25
Warsaw 25
Nuremberg 24
Dhaka 23
Brooklyn 22
Columbus 22
Hangzhou 22
Phoenix 21
Pune 21
Rome 20
Auburn Hills 18
Haiphong 18
Ningbo 18
Dublin 17
Johannesburg 17
Paris 17
Washington 17
Wuhan 17
Brasília 16
Istanbul 16
Pars 16
Falls Church 15
Manchester 15
Montreal 15
Belo Horizonte 14
San Francisco 14
Curitiba 13
Guayaquil 13
Kilburn 13
Munich 13
Totale 260.350
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.748
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.844
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.626
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.549
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.532
Multiple Sclerosis and environmental factors. 3.291
Gold - Old drug with new potentials 3.222
Simple solid-phase spectrophotometric method for free iron(III) determination 3.077
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.933
Sampling variability in hepatic iron concentration in beta-thalassemia 2.871
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.796
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.751
The essential metals for humans: a brief overview 2.703
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.653
Looking at new ligands for chelation therapy 2.560
Sorption of ofloxacin and chrysodine by grape stalk. A representative case of biomass removal of emerging pollutants from wastewater 2.541
Depleted uranium and human health 2.466
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.442
Copper-Induced Epigenetic Changes Shape the Clinical Phenotype in Wilson's Disease 2.424
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.410
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.297
Gold nanoparticles: A new golden Era in oncology? 2.274
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.235
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.228
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.225
Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time 2.225
Do anti-diabetic drugs act as copper ligands? 2.210
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.203
Free fluoride determination in honey by ion-specific electrode potentiometry: method assessment, validation and application to real unifloral samples 2.198
Toxicity of nanoparticles: etiology and mechanisms 2.153
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.114
Arsenic toxicity: Molecular targets and therapeutic agents 2.077
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.074
Tungsten or wolfram: Friend or foe? 2.051
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.037
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 2.029
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.972
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.965
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.957
Kill or cure: Misuse of chelation therapy for human diseases 1.923
The meaning of aluminium exposure on human health and aluminium-related diseases 1.911
A portable, disposable, and low-cost optode for sulphide and thiol detection 1.898
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.894
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.892
Silver coordination compounds: A new horizon in medicine 1.868
Inexpensive Alizarin Red S-based optical device for the simultaneous detection of Fe(III) and Al(III) 1.848
Alarming use of chelation therapy 1.847
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.835
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.826
Chemical features of in use and in progress chelators for iron overload 1.826
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.822
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.797
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.797
State of art in chelating agents for the clinical treatment of metal poisoning 1.791
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.777
Noble metals in medicine: Latest advances 1.777
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.776
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.764
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.760
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.734
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.730
Chelating agents as therapeutic compounds - Basic principles 1.712
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.708
Medical uses of silver: history, myths and scientific evidence 1.705
null 1.693
Sorption of chrysoidine by row cork and cork entrapped in calcium alginate beads 1.684
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.673
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.650
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.624
Uneven hepatic copper distribution in Wilson's disease 1.611
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.611
Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)? 1.586
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.577
Chelating agents for human diseases related to aluminium overload 1.559
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification 1.522
Uneven cardiac iron distribution in beta-thalassemia 1.511
Biomass against emerging pollution in wastewatee 1.485
Medicinal bio-inorganic chemistry: papers from the Third International Summer School of Bioinorganic Medicinal Chemistry, Cagliari, Italy 1.432
Toxicity of nanoparticles 1.386
Optimization of a newly established gas-chromatographic method for determining lactose and galactose traces: Application to Pecorino Romano cheese 1.386
Development of a sensor for trivalent iron: AHP fixed on mesoporous silica 1.316
Copper(II) and Nickel(II) uptake from aqueous solutions by cork wastes: a NMR and potentiometric study 1.306
Chelating agents for metal intoxication 1.305
The Potential Clinical Properties of Magnesium 1.299
Biomass against emerging pollution in wastewater: Ability of cork for the removal of ofloxacin from aqueous solutions at different pH 1.261
Deferoxamine-paper for iron(III) and vanadium(V) sensing 1.245
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.238
Iron chelating agents for iron overload diseases 1.237
Molecular recognition between adenine or 2,6-diaminopurine and copper(II) chelates with N,O2,S-tripodal tetradentate chelators having thioether or disulfide donor groups. 1.235
Metal ion toxicity 1.234
Warns against unapproved ‘chelation therapy’ 1.200
null 1.188
Medical therapy of patients contaminated with radioactive cesium or iodine 1.163
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.162
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.159
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.151
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.113
null 1.075
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.070
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 1.056
Totale 196.184
Categoria #
all - tutte 355.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 355.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.600 0 0 0 0 0 0 0 0 0 3.471 2.941 2.188
2021/202212.527 1.465 1.310 696 960 1.077 949 652 479 891 1.213 1.478 1.357
2022/202317.894 1.410 1.911 2.066 1.412 1.487 2.109 997 2.372 1.204 920 1.158 848
2023/202419.038 1.041 839 846 1.302 2.034 3.370 2.863 1.276 726 1.437 1.687 1.617
2024/202541.563 10.259 11.022 4.737 3.838 2.235 2.611 3.586 261 510 1.530 404 570
2025/202612.981 754 497 1.452 896 657 949 2.547 1.029 3.135 1.065 0 0
Totale 270.208